Skip to main content
. 2016 Apr 25;11(4):e0154214. doi: 10.1371/journal.pone.0154214

Table 2. PLA-SOX10 vs. Cobas-s100 in 72 MM patients.

Stage TIS1 I (T1) I (T2) II III-IV
SOX10 positive 2(20%) 4(24%) 0 1(11%) 9(35%)
S100 positive 1(10%) 2(12%) 0 2(22%) 8(29%)
SOX10 and S100 positive 0 1(6%) 0 0 2(8%)
Total n = 10 n = 17 n = 9 n = 9 n = 27

1TIS, Tumor in situ.